サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ジェネリック医薬品の世界市場：タイプ別、投与経路別、製品別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
市場調査レポート
商品コード
1339904

ジェネリック医薬品の世界市場：タイプ別、投与経路別、製品別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測

Generic Pharmaceuticals Market with COVID-19 Impact Analysis, By Type, By Route of Administration, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 374 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ジェネリック医薬品の世界市場：タイプ別、投与経路別、製品別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年08月01日
発行: AnalystView Market Insights
ページ情報: 英文 374 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のジェネリック医薬品の市場規模は、2022年は3,617億100万米ドルとなり、2023年から2030年にかけてCAGR 8.31%で拡大すると予想されています。

ジェネリック医薬品市場 - 市場力学

  • 慢性疾患の増加
  • 慢性疾患の罹患率の上昇は、ジェネリック医薬品市場の主要促進要因のひとつです。慢性疾患と診断される人が増えるにつれて、その治療のために追加の医薬品を求めるようになります。ブランド医薬品は高価だが、ジェネリック医薬品は安価で、ブランド医薬品と同じ化学構造を持つ。患者は、ジェネリック医薬品のコストの低さ、化学的組成の一貫性、効力の高さから、ブランド薬よりもジェネリック医薬品を選ぶ。慢性疾患の治療期間が延長された結果、ジェネリック医薬品の売上も増加しています。例えば、WHO（世界保健機関）は、今後10年間に慢性疾患関連の死亡者数が17％増加すると予測しています。

ジェネリック医薬品市場 -　セグメンテーション分析

  • 世界のジェネリック医薬品市場は、タイプ、投与経路、製品、用途、地域によって区分されます。
  • 市場はタイプ別でシンプルジェネリック、スペシャリティジェネリック、バイオシミラーに分けられる。市場を独占しているのは簡易ジェネリック医薬品です。シンプルジェネリック医薬品は生物学的同等性試験を実施する必要があり、明確な開発計画と規制アプローチが必要です。これらの品目は化学的に基準品と同一であり、市場はすでにシンプルジェネリック医薬品で溢れかえっています。とはいえ、医薬品に対するヘルスケア支出を削減し、新規承認や上市を増やそうとする政府の試みの結果、市場は拡大すると予想されます。
  • 市場は投与経路によって経口剤、注射剤、吸入剤、その他に分けられる。市場を独占しているのは経口セグメントです。経口投与の簡便性や看護の必要性のなさなど多くの利点が、患者の受容性とコンプライアンスを高めています。COVID-19患者の治療のために、Zenera Pharma社は2022年9月にパクスロビドのジェネリック医薬品を発売しました。ニルマトルビル20錠を含むこれらの経口薬の1箱の価格は63.74米ドルです。

ジェネリック医薬品市場 - 地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開している国によってさらに分けられます。ジェネリック医薬品の製品上市数と需要の増加と相まって、有利な政府の取り組みが増加していることが、北米地域の主要な収益要因となっています。

ジェネリック医薬品市場 - 競合情勢

  • 今後数年間、空調需要が継続的に開拓されるため、空対空ヒートポンプの世界市場は海外メーカーと現地メーカーの両方で構成されており、世界で最も競争の激しい分野の1つとなっています。各社は、企業ウェブサイト、eコマース・ウェブサイト、小売業者、流通業者、最終消費者など、さまざまなチャネルを通じて製品を販売しています。製品メーカーは、製品コスト、性能、製品作り、流通、評判、入手可能性など、さまざまな側面で競争しています。
  • リーチを強化し、市場シェアを拡大するために企業が使用する主な手法には、新製品の発売、製品ネットワークの開発、研究開発費、M&Aなどがあります。例えば、2022年11月、米国保健当局はグレンマーク・ファーマシューティカルズに対し、尿素サイクル障害の治療薬であるフェニル酪酸ナトリウム錠の米国での販売許可を与えました。

目次

第1章 ジェネリック医薬品市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ジェネリック医薬品の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 ジェネリック医薬品産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ジェネリック医薬品市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 ジェネリック医薬品市場情勢

  • ジェネリック医薬品市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ジェネリック医薬品市場 - タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • シンプルジェネリックス
    • スペシャルティジェネリック
    • バイオシミラー

第8章 ジェネリック医薬品市場 - 投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口
    • 注射
    • 吸入
    • その他

第9章 ジェネリック医薬品市場 - 製品別

  • 概要
    • 製品別セグメントシェア分析
    • 低分子
    • 高分子

第10章 ジェネリック医薬品市場 - 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 中枢神経系疾患
    • 呼吸器疾患
    • ホルモンと関連疾患
    • 消化器疾患
    • 心血管疾患
    • 感染症
    • がん
    • 糖尿病
    • その他

第11章 ジェネリック医薬品市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - ジェネリック医薬品業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Zydus Cadila
    • Torrent Pharmaceuticals
    • Teva Pharmaceutical Industries
    • Sun Pharmaceutical Industries
    • Sandoz（a subsidiary of Novartis）
    • Mylan（now part of Viatris）
    • Lupin Pharmaceuticals
    • Hikma Pharmaceuticals
    • Glenmark Pharmaceuticals
    • Fresenius Kabi
    • Endo International（through its subsidiary Par Pharmaceutical）
    • Dr. Reddy's Laboratories
    • Cipla
    • Aurobindo Pharma
    • Apotex

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Generic Pharmaceuticals Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Generic Pharmaceuticals Market, by Type 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Generic Pharmaceuticals Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Generic Pharmaceuticals Market, by Product 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Generic Pharmaceuticals Market, by Application 2018-2030 (USD Million)
  • TABLE Generic Pharmaceuticals Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Generic Pharmaceuticals Market, by Region 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Generic Pharmaceuticals Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Generic Pharmaceuticals Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Europe Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Asia Pacific Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Latin America Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Germany Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE India Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Brazil Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Generic Pharmaceuticals Market share analysis by country, 2022
  • FIGURE Saudi Arabia Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Generic Pharmaceuticals Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1628

REPORT HIGHLIGHT

Generic Pharmaceuticals Market size was valued at USD 361,701.0 Million in 2022, expanding at a CAGR of 8.31% from 2023 to 2030.

Generic medicines are non-branded drugs with the same active components, dosage form, potency, and intended purpose as brand-name drugs. Following the termination of the patent protection for the original medicine, these products are created and marketed. To assure their safety, quality, and efficacy, generic medications must pass stringent regulatory clearance procedures. Generic medicines are often less expensive than name-brand medications since there are no expenditures associated with research and development. While preserving similar therapeutic efficacy to their branded versions, they help extend access to vital pharmaceuticals and are crucial in lowering healthcare costs.

Generic Pharmaceuticals Market- Market Dynamics:

  • Increasing incidence of chronic diseases.
  • The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more people are given a chronic disease diagnosis, they seek out additional medications to treat it. Branded medications cost more, whereas generic medications cost less and share the same chemical make-up as branded medications. Patients choose generic medications over branded medications due to the lower cost, consistency in chemical makeup, and potency of generic medications. As a result of the extended duration of therapy for chronic diseases, generic medicine sales also rise. For instance, the WHO (World Health Organization) predicts a 17% rise in the number of chronic disease-related fatalities during the next ten years.

Generic Pharmaceuticals Market- Key Insights:

  • As per the analysis shared by our research analyst, the global generic pharmaceutical market is estimated to grow annually at a CAGR of around 8.31% over the forecast period (2023-2030)
  • Based on type segmentation, simple generic products were predicted to show maximum market share in the year 2022
  • Based on application, cardiovascular was the leading type in 2022
  • Based on product segmentation, the small molecule was the leading type in 2022
  • Based on route of administration segmentation, oral was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Generic Pharmaceuticals Market- Segmentation Analysis:

  • The Global Generic Pharmaceuticals Market is segmented based on Type, Route of Administration, Product, Application, and Region.
  • The market is divided into categories based on Type: Simple Generics, Specialty Generics, and Biosimilars. The Simple Generics sector dominates the market. The simple generic products need to conduct bioequivalence studies and have a defined development plan and regulatory approach. These items are chemically identical to their reference counterparts, and the market is already overflowing with straightforward generic products. Nevertheless, the market is anticipated to expand as a result of government attempts to cut healthcare spending on medicines and increase new approvals and launches.
  • The market is divided into categories based on Route of Administration: Oral, Injectable, Inhalable, and Others. The oral segment dominates the market. The many benefits of oral dose, including its simplicity and lack of nursing needs, increase patient acceptance and compliance. For the treatment of COVID-19 patients, Zenera Pharma introduced a generic version of Paxlovid in September 2022. Each box of these oral medications, which contains 20 Nirmatrelvir pills, costs USD 63.74.

Generic Pharmaceuticals Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. An increasing number of favorable government initiatives coupled with the rising number of product launches and demand for generic drugs is a key revenue driver in North American region.

Generic Pharmaceuticals Market- Competitive Landscape:

  • Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution, reputation, and availability.
  • Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, Product network development, R&D spending, and mergers and acquisitions. For instance, in November 2022, The US health authority gave Glenmark Pharmaceuticals permission to sell sodium phenylbutyrate tablets, a medication used to treat urea cycle disorders, in the US.

Recent Developments:

In October 2022, Generic Fingolimod capsules, utilized for the treatment of multiple sclerosis, were introduced to the American market by Glenmark's American-based division.

Key features of the study:

  • This proposed research study on Generic Pharmaceuticals market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Generic Pharmaceuticals market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Generic Pharmaceuticals market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Generic Pharmaceuticals market
  • Impact of COVID-19 on Generic Pharmaceuticals market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Generic Pharmaceuticals market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Generic Pharmaceuticals market, we have also included competitive landscape and key innovator analysis for the Generic Pharmaceuticals market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Generic Pharmaceuticals market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Generic Pharmaceuticals market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENERIC PHARMACEUTICALS MARKET KEY PLAYERS

  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Sandoz (a subsidiary of Novartis)
  • Mylan (now part of Viatris)
  • Lupin Pharmaceuticals
  • Hikma Pharmaceuticals
  • Glenmark Pharmaceuticals
  • Fresenius Kabi
  • Endo International (through its subsidiary Par Pharmaceutical)
  • Dr. Reddy's Laboratories
  • Cipla
  • Aurobindo Pharma
  • Apotex

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY TYPE

  • Simple Generics
  • Specialty Generics
  • Biosimilars

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Injectable
  • Inhalable
  • Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY PRODUCT

  • Small Molecule
  • Large Molecule

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY APPLICATION

  • Central Nervous System Disorders
  • Respiratory Diseases
  • Hormones & Related Diseases
  • Gastrointestinal Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Cancer
  • Diabetes
  • Others

GLOBAL GENERIC PHARMACEUTICALS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Generic Pharmaceuticals Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Generic Pharmaceuticals Market Snippet by Type
    • 2.1.2. Generic Pharmaceuticals Market Snippet by Route of Administration
    • 2.1.3. Generic Pharmaceuticals Market Snippet by Product
    • 2.1.4. Generic Pharmaceuticals Market Snippet by Application
    • 2.1.5. Generic Pharmaceuticals Market Snippet by Country
    • 2.1.6. Generic Pharmaceuticals Market Snippet by Region
  • 2.2. Competitive Insights

3. Generic Pharmaceuticals Key Market Trends

  • 3.1. Generic Pharmaceuticals Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Generic Pharmaceuticals Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Generic Pharmaceuticals Market Opportunities
  • 3.4. Generic Pharmaceuticals Market Future Trends

4. Generic Pharmaceuticals Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Generic Pharmaceuticals Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Generic Pharmaceuticals Market Landscape

  • 6.1. Generic Pharmaceuticals Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Generic Pharmaceuticals Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Simple Generics
    • 7.1.3. Specialty Generics
    • 7.1.4. Biosimilars

8. Generic Pharmaceuticals Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable
    • 8.1.4. Inhalable
    • 8.1.5. Others

9. Generic Pharmaceuticals Market - By Product

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 9.1.2. Small Molecule
    • 9.1.3. Large Molecule

10. Generic Pharmaceuticals Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 10.1.2. Central Nervous System Disorders
    • 10.1.3. Respiratory Diseases
    • 10.1.4. Hormones & Related Diseases
    • 10.1.5. Gastrointestinal Diseases
    • 10.1.6. Cardiovascular Diseases
    • 10.1.7. Infectious Diseases
    • 10.1.8. Cancer
    • 10.1.9. Diabetes
    • 10.1.10. Others

11. Generic Pharmaceuticals Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Generic Pharmaceuticals Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Generic Pharmaceuticals Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Generic Pharmaceuticals Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Generic Pharmaceuticals Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Generic Pharmaceuticals Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Generic Pharmaceuticals Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Zydus Cadila
    • 12.2.2. Torrent Pharmaceuticals
    • 12.2.3. Teva Pharmaceutical Industries
    • 12.2.4. Sun Pharmaceutical Industries
    • 12.2.5. Sandoz (a subsidiary of Novartis)
    • 12.2.6. Mylan (now part of Viatris)
    • 12.2.7. Lupin Pharmaceuticals
    • 12.2.8. Hikma Pharmaceuticals
    • 12.2.9. Glenmark Pharmaceuticals
    • 12.2.10. Fresenius Kabi
    • 12.2.11. Endo International (through its subsidiary Par Pharmaceutical)
    • 12.2.12. Dr. Reddy's Laboratories
    • 12.2.13. Cipla
    • 12.2.14. Aurobindo Pharma
    • 12.2.15. Apotex

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us